Derm Cases · Medicine
OSCE — Porokeratosis
Eight-minute OSCE station on Porokeratosis: focused history, examination priorities, investigations, emergency and definitive management.
On this page
Study tools
Target exams
Brief (to candidate)
You will assess a patient with a presentation consistent with Porokeratosis.
You have 8 minutes to take a focused history, outline examination, investigations, and management including red flags.
Clinical context
Porokeratosis is a clonal disorder of epidermal keratinisation, defined histologically by the PATHOGNOMONIC CORONOID LAMELLA — a vertical column of parakeratotic cells overlying a diminished granular layer with underlying dyskeratotic keratinocytes. Five classical variants are recognised: classic porokeratosis of Mibelli (large plaque, childhood onset), disseminated superficial actinic porokeratosis (DSAP, most common, sun-exposed adult skin, autosomal dominant with MVK/SLC17A9 mutations), linear porokeratosis along Blaschko's lines (highest malignant potential), porokeratosis palmaris et plantaris disseminata (palms/soles first), and punctate porokeratosis (1–2 mm keratotic spines on palms/
[2]Candidate tasks
- Clarify onset, severity, associated features, and red-flag symptoms.
- State focused examination priorities.
- List first-line investigations and any named score/criteria.
- Give immediate resuscitation steps.
- Outline definitive management with doses/routes where standard.
- Name complications and disposition (ward / HDU / theatre / discharge safety-net).
- Mention one special-population modifier (pregnancy, child, elderly, CKD).
- Give immediate resuscitation steps.
- Outline definitive management with doses/routes where standard.
- Name complications and disposition (ward / HDU / theatre / discharge safety-net).
- Mention one special-population modifier (pregnancy, child, elderly, CKD).
Examiner checklist
| Domain | Pass behaviours |
|---|---|
| Definition | Correct working diagnosis language |
| Assessment | Focused, prioritised, red flags sought |
| Investigations | Appropriate first-line + interpretation |
| Emergency care | ABC / time-critical actions first |
| Definitive care | Specific drugs/procedures, not generic phrases |
| Safety | Induration, ulceration, rapid growth or pain in a long-standing porokeratosis le |
| Safety | Linear porokeratosis — highest malignant transformation rate (up to 7–11% in som |
| Safety | Sudden eruptive porokeratosis in an adult without sun/immunosuppression trigger |
| Communication | Clear plan and safety-netting |
Model outline
Lead with the working diagnosis and life threats. Resuscitate before definitive tests when unstable. Use guideline-standard therapy with named agents and doses. Document escalation criteria and follow-up. A safe candidate is specific, structured, and never delays critical care for non-urgent imaging.[1]
References2ShowHide
- [1]Velasco-Tamariz V, et al. Porokeratosis: A Review of Its Pathophysiology, Clinical Manifestations, Diagnosis, and Treatment. Actas dermo-sifiliograficas, 2020.PMID 32401728
- [2]Zhou Y, et al. Identification of three mutations in the MVK gene in six patients associated with disseminated superficial actinic porokeratosis. Journal of dermatological science, 2016.PMID 26794421